Latest news with #Cramer
Yahoo
9 hours ago
- Business
- Yahoo
Was Jim Cramer Right About Eli Lilly and Company (LLY)?
We recently published a list of In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. In that episode, a caller asked about Eli Lilly and Company (NYSE:LLY), particularly in relation to the competition with Novo Nordisk and its weight-loss drugs at the time. Cramer was enthusiastic back then, saying: 'We had this group 100X on the other day and they did a study about how people feel about Lilly versus Wegovy — about how they feel about Zepbound versus the product from Novo Nordisk — and without a doubt, in a head-to-head contest, Lilly is so far and away the winner. I just say you've got to own the stock. Let's hope it comes in so we can buy more.' Cramer's bullish stance was premature as Eli Lilly fell 11.72%. Eli Lilly and Company (NYSE:LLY) remains a leader in obesity and diabetes treatment innovation, with Zepbound driving major growth in the pharmaceutical pipeline. Despite the setbacks, Cramer recently advised a caller of the show to buy more. Here's what he said on May 12: 'I want you to buy more… The reason why you want to buy it is because there was definitive data that came out last night about Novo Nordisk not being anywhere near as good as Eli Lilly when it comes to weight loss, which is what a lot of people are in the GLP for. And it was not reflected because the things were so crazed because of what the president announced. I think the stock could be up a hundred points when people realize, wait a second, it is definitively better than Novo. I would buy Eli Lilly handover fist.' Overall, LLY ranks 2nd on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about this cheapest AI stock. cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
9 hours ago
- Business
- Yahoo
Was Jim Cramer Right About Sony Group Corporation (SONY)?
We recently published a list of In this article, we are going to take a look at where Sony Group Corporation (NYSE:SONY) stands against other stocks that Jim Cramer discusses. In that older episode, a caller brought up Sony Group Corporation (NYSE:SONY), pointing out that the stock was underappreciated despite strong fundamentals, a stock split, dividend boost, and buyback. Cramer said: 'I like it. They've got to get out of this… They've got to tell me, 'Listen, we're not interested in a takeover,' because I just like the stock as is. And it's been weighed down by the takeover talk.' A team of content creators using the latest devices and software to produce high-quality animation and motion pictures. Cramer's faith in Sony paid off handsomely with a 58.99% gain. Sony Group Corporation (NYSE:SONY) blends gaming, entertainment, and consumer electronics under one powerhouse brand, with PlayStation as a major growth driver. Overall, SONY ranks 3rd on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of SONY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SONY and that has 100x upside potential, check out our report about this cheapest AI stock. cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
CNBC
11 hours ago
- Business
- CNBC
Jim Cramer on Abercrombie and American Eagle earnings: Limit downside on teen retailers
CNBC's Jim Cramer on Friday reviewed recent earnings from teen-focused apparel makers Abercrombie & Fitch and American Eagle Outfitters. While he was more optimistic about the former, he was generally cautious on the group. "I want you to limit your downside with these teen retailers. You never know when a company like this may go from sink and swim to just plain sink, at least for the next quarter," he said. "But to me, Abercrombie — I think that's worth buying perhaps as soon as next week." According to Cramer, teenage consumers are "notoriously fickle," a dynamic that makes it hard to bet on stocks that rely on them. Retailers and consumer-oriented companies broadly have expressed worries about the economic impact of President Donald Trump's tariffs, as most manufacture abroad. Abercrombie & Fitch is down 47.49% year-to-date while American Eagle is down 34.25%. He was disappointed with American Eagle's quarter — the retailer missed on earnings, recording a $75 million write-down in spring and summer merchandise. The company also reduced its full-year guidance before the report because of macroeconomic uncertainty. Cramer said it was strange that American Eagle announced a $200 million buyback while business is weaker. Retailers need flexibility, he said, and American Eagle's buyback will give the company less flexibility. Abercrombie & Fitch managed to beat the estimates, but it cut guidance as it gears up to weather steep tariffs. However, Cramer expressed confidence in CEO Fran Horowitz, who has managed to overhaul the company and execute a substantial turnaround after the brand struggled for years, having previously garnered a reputation for exclusivity, toxicity and racism. He was impressed with the retailer's efforts to diversify its supply chain. He noted that its offshoot brand, Hollister, grew same stores sales while they declined for the namesake brand, which is targeted at slightly older crowd. If investors believe Hollister can keep up the momentum and the flagship brand can improve, Cramer said the stock could be bought. He also said a Monday JPMorgan event featuring top Abercrombie management could move the stock. "I don't usually recommend options here, but I can tell you that teens are so fickle that if I were to buy Abercrombie ahead of the talk at JP Morgan on Tuesday, I actually might even do it with deep in the money calls," Cramer said. Abercrombie & Fitch and American Eagle did not immediately respond to request for comment. Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest
Yahoo
20 hours ago
- Politics
- Yahoo
Max Planck Society sees flood of US job applicants amid Trump swoop on universities
By Thomas Escritt BERLIN (Reuters) -Uncertainty over the future of U.S. universities under President Donald Trump's administration has fuelled a threefold surge in U.S. applications to the Max Planck Society, one of Europe's leading research bodies. Changes in funding for research centres, coupled with the administration's move last week - temporarily blocked by a judge - to ban international students from Harvard, have cast a pall over the United States' world-leading science infrastructure. Trump's crackdown, which has already seen prominent academics like historian Timothy Snyder, a scholar on authoritarianism, quit Yale for a post in Canada, has led top scientists to look to Europe, data indicates. The Max Planck Society, a German state-backed network of research centres, received 81 applications from the U.S. this spring in its latest call for promising early-career women scientists looking to set up their own research labs. Last year's call received 25 applications. "What's interesting is the number of applications from other parts of the world remained constant," said Patrick Cramer, president of the Max Planck Society. "If you look at which institutions these applications are coming from, you see almost half are concentrated at five (U.S.) institutions: Harvard, Stanford, MIT, the National Institutes of Health and the University of California." With an annual budget of over 2 billion euros ($2.3 billion) and a staff of 25,000 spread over its 84 research centres, as well as 39 Nobel prizes to its name, Max Planck is one of the few outfits worldwide that can offer facilities comparable with top-drawer U.S. institutions. Cramer said the society planned to allocate extra funds to hire as many as 20 of the applicants rather than the planned 12 if the overall quality was as high as expected. Research organisations across Europe are making plans for what they expect to be a glut of top scholars hit by the turbulence in U.S. education. Freshly back from a trip to the U.S., Cramer said the main topic of discussion was how research organisations elsewhere could minimise the damage done to the advancement of science. "It came up again and again: our main concern is to ensure that we don't lose too many talented people in this generation to global science. We have to try and offer a safe haven in Europe where we can absorb talent to bridge the coming years." The Trump administration revoked Harvard University's ability to enrol international students last week and is forcing current foreign students to transfer to other schools or lose legal status, while also threatening to expand the crackdown to other colleges. Germany's new government plans a "1,000 brains" programme of expanded research capacity in response to the upheaval in U.S. higher education but, at a time of economic headwinds, universities across Europe face resource constraints. Regardless, global science cannot shrug off the impact of the winds buffeting U.S. higher education, said Petra Olschowski, research minister in the state of Baden-Wuerttemberg who oversees four of Germany's 11 leading universities. "Harvard, the other major U.S. universities set the bar: this is the benchmark we want to achieve," she said. "And it's precisely this constellation that is being wounded." ($1 = 0.8808 euros)
Yahoo
a day ago
- Business
- Yahoo
The Coca-Cola Company (KO) Might Be Clawing Back Market Share, Believes Jim Cramer
We recently published a list of . In this article, we are going to take a look at where Coca-Cola Company (NYSE:KO) stands against other stocks that Jim Cramer discusses. The Coca-Cola Company (NYSE:KO) is the largest carbonated beverage company in the world. Cramer has discussed the firm several times this year. In April, he wondered whether the firm's shares could stick with their momentum as they had managed to weather the storm in the consumer products sector. The Coca-Cola Company (NYSE:KO)'s peer Pepsi has struggled recently as weight loss drugs change the firm's end-market. The shares are up by 16% year-to-date and have gained 3.8% in May. The gains appear to have come on the back of lowering trade tensions between the US and China. Here are Cramer's recent comments about The Coca-Cola Company (NYSE:KO): 'I actually like Coke, Coke may be coming back [in] market share.' A row of factory workers assembling bottles of sparkling soft drinks on a conveyor belt. As markets sold off in April after the tariff announcements, The Coca-Cola Company (NYSE:KO's shares actually gained 3% to reflect the firm's defensive nature. In fact, the share price gain reflected Cramer's prescience as he had remarked before the tariff announcements: 'In terms of shorting, like if you wanna short, do you short Coca-Cola? No, cause Coca-Cola in 2000, after the NASDAQ broke, was really a terrific stock to own.' Overall, KO ranks 3rd on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of KO, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KO and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
